Neuro20 and the Evolution of Neuromodulation

How advanced neuromodulation technology is transforming rehabilitation and recovery, from clinical research to the EMS suit you'll find in our Lenexa clinic.

For more than 50 years, EMS (Electrical Muscle Stimulation) has been studied and used for pain relief, strength, and recovery from injury, but the technology wasn't developed enough to make a significant difference. Until now.

Neuro20 has taken the old science, added new research discoveries and created a cutting-edge, FDA-cleared, drug-free, non-invasive wearable system that's transforming how people move.

Whether it's spinal cord injuries, long COVID, stroke recovery, or other orthopedic and chronic conditions, the Neuro20 Smart Suit is giving people a new way to regain movement.

What is the Neuro20 PRO Smart Suit?

The Neuro20 PRO Smart Suit is a full-body wearable device that uses electrical stimulation to activate muscle fibers, engaging over 42 muscle groups to boost performance and recovery. It has 20 large silver-lined cloth electrodes and is designed for musculoskeletal and neuromuscular conditions.

Key Components of the Neuro20 PRO System

• Neuro20 PRO Smart Suit: a whole-body suit that stimulates muscles to enhance movement, strength, and recovery.
• Software: advanced programs control the electrical stimulation, designed to help muscle re-education, improve circulation, and more. It includes 4 programs (strength, conditioning, sequential patterns, and massage) together with 9 modes to target specific needs.
• Control box: a rechargeable device that connects to the suit in a holster, sends electrical impulses to the electrodes, and is controlled wirelessly via a tablet.

FDA-Cleared Uses

The Neuro20 PRO System is FDA-cleared to:

• Improve muscle performance
• Re-educate muscles
• Increase circulation
• Maintain or improve range of motion
• Relax muscle spasms
• Prevent muscle atrophy

In June 2024, Neuro20 published a white paper on how whole-body electrical stimulation supports people with long COVID in regaining mobility. Contact us to learn more.

← Back to all articles